Clinical Trial Update: Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height [Phase 3]

View source ↗

Summary

Pfizer's Genotropin (somatropin) was studied in a Phase 3 trial for treating short stature in children born small for gestational age; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders
• Short Stature

Drugs mentioned

• GENOTROPIN (SOMATROPIN)

Snippet

Sponsor: Pfizer | Conditions: Growth Disorder | Phase 3 | Status: COMPLETED